90490 ⎘
Indexing scheme relating to specific properties of organic compounds Isotopically modified compounds, e.g. labelled
CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF
#1202ISOTOPICALLY LABELED BILE ACID DERIVATIVES
#1203EGFR inhibitors
#1204ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF
#1205Pyridinone MK2 inhibitors and uses thereof
#1206Nitrogen-containing compound, and electronic element and electronic device using same
#1207COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#1208Organic electroluminescence element and electronic device
#1209PFKFB3 INHIBITORS AND THEIR USES
#1210COMPOUNDS FOR ELECTRONIC DEVICES
#1211Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors
#1212Heterocyclic compound
#1213ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1214DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES
#1215Heterocyclic inhibitors of ENPP1
#1216ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1217AZOLE-FUSED PYRIDAZIN-3(2H)-ONE DERIVATIVES
#1218EGFR inhibitors
#1219TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF
#1220Methods for practical synthesis of deuterated amino acids
#1221NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS
#1222Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
#1223VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES
#1224LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME
#1225Organic electroluminescence device and electronic apparatus provided with the same
#1226Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device
#1227Inhibitors of APOL1 and methods of using same
#1228Inhibitors of SARM1
#1229NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE INCLUDING SAME
#1230ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1231ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1232ORGANIC LIGHT-EMITTING ELEMENT
#1233NOVEL BORON COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME
#1234ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1235Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents
#1236Cot modulators and methods of use thereof
#1237CDK KINASE INHIBITOR
#1238Derivatives of resiquimod
#1239Tricyclic compounds as histone methyltransferase inhibitors
#1240ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#1241NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
#1242GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS
#1243HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT
#1244Modulators of ATP-binding cassette transporters
#1245RADIOISOTOPE LABELED COMPOUND FOR IMAGING OR TREATMENT OF PROSTATE CANCER
#1246COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
#12473,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
#1248Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#1249Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
#1250ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1251ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1252Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device
#1253ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1254Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders
#1255HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE
#1256Crystal of 1,3,5-triazine derivative or solvate thereof and method for producing same
#1257COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
#1258METHOD FOR PREPARING DEUTERATED ORGANIC COMPOUNDS
#1259Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
#1260Compound and organic light-emitting device comprising same
#1261ORGANIC LIGHT EMITTING DEVICE
#1262RHO KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
#1263COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1264LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#1265COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#1266MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS
#1267ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES
#1268Nitrogen-containing compound, organic electroluminescent device, and electronic apparatus
#1269ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE
#1270CYCLOALKYL 3-OXOPIPERAZINE CARBOXAMIDES AND CYCLOHETEROALKYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS
#12711H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
#1272CANNABINOID DERIVATIVES, PRECURSORS AND USES
#1273ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1274CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATING AGENTS
#1275DEUTERATED COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
#1276ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1277METHODS AND MATERIALS FOR MAKING PET RADIOTRACERS
#1278T-TYPE CALCIUM CHANNEL BLOCKER
#1279AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
#1280SYNTHESIS OF DEUTERATED ALDEHYDES
#1281ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1282REAGENTS AND METHODS FOR LABELING MOLECULES WITH ASTATINE ISOTOPES IN HIGHER OXIDATION STATES
#1283HETEROCYCLIC DERIVATIVES AND USE THEREOF
#1284Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
#1285PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDS
#1286CXCR4 Receptor Antagonists
#1287ORGANIC ELECTROLUMINESCENT ELEMENT
#1288ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1289ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1290HETEROCYLIC COMPOUND AND LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE HETEROCYCLIC COMPOUND
#1291HEXAHYDRO-1H-PYRAZINO[1,2-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#1292COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES
#1293METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN
#1294CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME
#1295COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
#1296ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
#1297ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1298ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#1299Bicyclic heteroaromatic ring derivative
#1300Halogen-substituted phenylate compound and applications thereof
#1301Deuterated etoricoxib, methods of manufacture, and use thereof
#1302Substituted bicyclic compounds
#1303COMPOSITIONS AND METHODS FOR PREPARING REGIO- AND STEREOSELECTIVE ALICYCLIC ALKENE ISOTOPOLOGUES AND STEREOISOTOPOMERS
#1304Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#1305COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1306Organic light emitting device and display apparatus
#1307Organic compound, electronic device and electronic apparatus using same
#1308COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#1309LIGHT-EMITTING DEVICE
#1310Organic light emitting device
#1311POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
#1312Multi-Enzyme Nanoparticle-Assisted Stable Isotope Incorporation Into Small Molecules by Channeling
#1313Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
#1314ORGANIC COMPOUND, APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE
#1315Deuterated angiotensin-converting enzyme-2 (ACE-2) inhibitors
#1316NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#1317MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#1318MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR
#1319PROTEASOME ACTIVITY ENHANCING COMPOUNDS
#1320COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1321KIT FOR RADIOLABELLING WITH 68GA COMPRISING A METAL INHIBITOR
#1322Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#1323Himastatin derivatives, and processes of preparation thereof, and uses thereof
#1324NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS
#1325AMINOPYRAZINE COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF
#1326LIGANDS FOR IMAGING CARDIAC INNERVATION
#1327Nitrogen-containing compound, organic electroluminescent device and electronic apparatus
#1328Compounds
#1329COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF
#1330Compounds and their use for the treatment of alpha1-antitrypsin deficiency
#1331RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS
#1332KIT FOR RADIOLABELLING WITH 68GA COMPRISING A METAL INHIBITOR
#1333Deuterium-containing compound, and organic light-emitting device comprising same
#1334ORGANIC LIGHT-EMITTING DEVICE
#1335COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#1336Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#1337CARDIAC THERAPEUTIC
#1338Voltage gated sodium channel imaging agents
#1339MESCALINE DERIVATIVES WITH MODIFIED ACTION
#1340HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#1341COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
#1342DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
#1343METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX
#1344Compounds for chromatographic separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof
#1345HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
#1346Substituted pyrazole compounds, compositions containing same, and use thereof
#1347AUTOMATED ULTRA-COMPACT MICRODROPLET RADIOSYNTHESIZER
#1348F-labeled novel tetrazines imaging probes for pretargeting in PET imaging
#1349Methods for inhibiting the progression of neurodegenerative diseases
#1350Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device
#1351ISOTOPE MODIFIED NUCLEOTIDES FOR DNA DATA STORAGE
#1352NUCLEOTIDES WITH ISOTOPES FOR DNA DATA STORAGE
#1353Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device
#1354ADENOSINE 2 RECEPTOR ANTAGONISTS
#1355Organic Compound, Organic Light Emitting Diode and Organic Light Emitting Device Having the Compound
#1356Microtubule-associated protein Tau imaging compounds for Alzheimer's disease and precursors thereof
#1357Creatine prodrugs, compositions and methods of use thereof
#135818F-RADIOLABELED BIOMOLECULES
#1359PCSK9 INHIBITORS AND METHODS OF USE THEREOF
#1360METHOD FOR RADIOIODINATION OR RADIOASTATINATION OF A BIOMOLECULE
#1361NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#1362ORGANIC LIGHT EMITTING DEVICE
#1363Organic Light Emitting Device
#1364Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the same
#1365PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS
#13669H-pyrrolo-dipyridine derivatives
#1367INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF
#1368Aminopyrazine diol compounds as PI3K-γ inhibitors
#1369ORGANIC METAL COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND
#1370ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME
#1371FUSED TRICYCLIC COMPOUNDS USEFUL AS ANTICANCER AGENTS
#1372Deuterated colony stimulating factor-1 receptor (CSF-1R) inhibitors
#1373RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF
#1374ORGANOMETALLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND
#137518F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
#1376LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME
#1377Process for the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivatives
#1378ORGANIC COMPOUNDS
#1379Radiolabeled compound producing method and producing apparatus, radiolabeled compound and radioisotope producing apparatus
#1380ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#13814,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF
#1382Heterocyclic derivative and organic electroluminescent device thereof
#1383TYK2 pseudokinase ligands
#1384Tricyclic urea compounds as JAK2 V617F inhibitors
#1385Aromatic derivatives, preparation methods, and medical uses thereof
#1386DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST
#1387Therapeutic compositions comprising deuterated or partially deuterated N,N-dimethyltryptamine compounds
#1388SILYLATIONS OF AROMATIC SUBSTRATES WITH BASE-ACTIVATED ORGANOSILANES
#1389Imaging Agents
#13906-OXO-1,6-DIHYDROPYRIDAZINE PRODRUG DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE
#13914-hydroxybutyric acid analogs
#1392FLUORINATION METHOD
#1393[18F]-Labeled Benzothiazole Derivative As PET Radiotracer
#1394Inhibitors of lysine specific demethylase-1
#1395Method for detection and quantification of CLN3 protein
#1396INDOLE AHR INHIBITORS AND USES THEREOF
#1397IMIDAZOLONYLQUINOLINE COMPOUNDS AND THERAPEUTIC USES THEREOF
#1398Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer
#1399COMPOUNDS AND METHODS OF DEUTERATED XANOMELINE FOR TREATING NEUROLOGICAL DISORDERS
#1400Compounds, compositions, and methods
#1401SUBSTITUTED AMINO-THIOL AND AMINO-DISULFIDE COMPOUNDS, AND USES THEREOF
#1402HDAC6 inhibitors and imaging agents
#1403PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES
#1404ISOTOPICALLY MODIFIED COMPONENTS AND THERAPEUTIC USES THEREOF
#1405Organic electronic element comprising compound for organic electronic element and an electronic device thereof
#1406COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF
#1407METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE
#1408FAK inhibitor and drug combination thereof
#14092-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitor
#1410Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist
#1411Tricyclic compounds
#1412Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
#1413Deuterated tryptamine derivatives and methods of use
#1414MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 4
#1415ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1416COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
#1417STRUCTURALLY MODIFIED OPIOIDS FOR PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS
#1418Delivery System For Ayahuasca-Like Substances
#1419FORMULATIONS CONTAINING DEUTERATED DOMPERIDONE
#1420ESTERS AND CARBAMATES AS MODULATORS OF SODIUM CHANNELS
#1421Organic electroluminescence device
#1422ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1423Bicyclic dione compounds as inhibitors of KRAS
#1424HipK4 inhibitors and uses thereof
#1425NLRP3 INHIBITORS
#1426NOVEL SULFONEUREA COMPOUNDS
#1427ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
#14282-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#1429RADIOLABELED COMPOUNDS AND USES THEREOF
#1430Deuterated Forms And Derivatives Of Volinanserin
#1431Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#1432ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE
#1433Organic light-emitting element using polycyclic aromatic derivative compound
#1434Compositions and methods for treating CNS disorders
#1435Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors
#1436Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same
#1437PSMA BINDING DUAL MODE RADIOTRACER AND THERAPEUTIC
#1438Compound targeting norepinephrine transporter
#1439Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
#1440PSMA-binding agents and uses thereof
#1441Substituted pyridine derivatives as SARM1 inhibitors
#1442SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF
#1443Deuterated compounds
#1444ORGANIC COMPOUNDS
#1445KDM1A inhibitors for the treatment of disease
#1446Radioactive I-labeled larotrectinib compound and preparation method and application thereof
#1447MILD AND SITE-SELECTIVE 18F-LABELING OF SMALL MOLECULES AND/OR BIOMOLECULES VIA A THIOL-REACTIVE SYNTHON
#1448Dihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods
#1449Arylamine compound, light-emitting device including the same, and electronic apparatus including the light-emitting device
#1450Compositions and methods for treating cancer
#1451Tricyclic urea compounds as JAK2 V617F inhibitors
#1452Compounds for the Reduction of the Deleterious Activity of Extended Nucleotide Repeat Containing Genes
#1453Substituted benzothiophene analogs as selective estrogen receptor degraders
#1454Inhibitors of SARM1
#1455Methods of treating neurofibromatosis with perillyl alcohol
#1456LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#1457AROMATIC RING COMPOUND
#1458ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
#1459METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#1460Organometallic compound, light-emitting device including the same, and electronic apparatus
#1461Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device
#1462DEUTERATED CFTR POTENTIATORS
#1463Heterobiaryl compounds and imaging agents for imaging huntingtin protein
#1464N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of Disease
#14652'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF
#1466Delivery system for ayahuasca-like substances
#1467NOVEL COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME
#1468PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#1469Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Compounds and Uses Thereof
#1470Process for making biologically active compounds and intermediates thereof
#1471Preparation method for deuterated macrocyclic compound
#1472COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#14732-(2,4,5-SUBSTITUTED PHENYLAMINO) PYRIMIDINE DERIVATIVE AND CRYSTALLINE FORM B THEREOF
#1474Light-emitting device and electronic apparatus including the light-emitting device
#1475CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
#14763-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#1477Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#1478DEUTERATED COMPOUNDS AND USES THEREOF
#1479ISOTOPE LABELING FOR UNIVERSAL MULTIPLEXING OF METABOLITES
#1480DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
#1481Inhibitors of CXCR2
#1482ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF
#1483Pharmaceutical compounds and therapeutic methods
#1484Stable heavy isotopes in amide functional groups and uses thereof
#1485PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP
#1486Compounds for the treatment of respiratory diseases
#1487Half-curcuminoids as amyloid-beta pet imaging agents
#1488Half-curcuminoids as amyloid-β PET imaging agents
#1489NOVEL FORMULATION AND METHOD OF SYNTHESIS
#1490Deuterium-enriched pioglitazone
#1491Organic compound and organic light emitting diode and organic light emitting display device including the same
#1492Inhibitors of cyclin-dependent kinase 7 (CDK7)
#1493Crystalline forms of deuterium-enriched pioglitazone
#1494Deuterated N,N-dimethyltryptamine compounds
#14954-HYDROXYBUTYRIC ACID ANALOGS
#1496Organometallic compound and organic light-emitting device including the same
#1497HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#1498Indazole compound or salt thereof
#1499AMORPHOUS COMPOUNDS OF FORMULA (I) AND AMORPHOUS COMPOUNDS OF FORMULA (I) SALTS
#1500Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses